Oncology/EndocrineA Model of Primary Culture of Colorectal Cancer and Liver Metastasis to Predict Chemosensitivity
Introduction
Colorectal carcinoma is one of the most prevalent cancers in western countries 1, 2. Nearly 50% of patients suffering from colorectal cancer develop distant metastasis and receive systemic chemotherapy [3]. The number of effective drugs administered in this indication has grown rapidly in the recent years, and besides the classical antimitotic agents (fluorouracil, topoisomerase-I inhibitors, platinum analogs), we now found monoclonal antibodies (anti-EGF-R, anti VEGF-R), antiangiogenic agents, peptide combination, defense modifiers, and vaccines. However, these anticancer agents, often used in combination, are effective in 60% of cases so far, meaning that many patients are treated for some period with an ineffective drug with some degree of toxicity 4, 5, 6, 7, 8. A major challenge for medical oncology is, therefore, to predict tumor response or resistance to a given regimen in order to prescribe the most appropriate drug for each patient.
Tumor response and drug toxicity depend on numerous factors, including patient metabolism, pharmacogenetics [9], tumor environment, and molecular alterations found in the tumor [10]. In some cancer types, such as breast cancer, gene expression profile can help to identify sensitive and resistant tumors to a given drug [11]. In colorectal cancer, response to a given drug for a given patient is difficult to assess because patients frequently receive several drugs simultaneously or have received successively several lines of treatment. This drawback could be bypassed if tumor sensitivity could be tested in an appropriate and reproducible in vitro model. However, primary explant cultures of tumor fragments have been, to date, very disappointing for this purpose. Primary culture of tumor fragments are often contaminated by rapid growth of normal fibroblast, the tumor architecture is lost as well as the cell-cell interaction and in vitro models do not permit to apply the drug to be tested on the tumor cells only for a desirable period.
Poly-2-hydroxyethylmetacrylate (PolyHEMA) has been used to preserve three-dimensional organization of tumors [12]. This compound is also interesting because a drug washout process is permitted by the use of a liquid medium [13].
The aim of this study was to establish a model of primary culture of colorectal cancer fragments using PolyHEMA, to measure the efficacy of an antimitotic drug on cell proliferation in this model, and to correlates the results obtained in vitro to the chemosensitivity in vivo observed in the same patients.
Section snippets
Generation and Culture of HT29 Nodules
The cell line HT29 issued from a human colon tumor was purchased at the ATCC (Rockville, MD). Cells were routinely maintained in monolayer with Dulbecco modified Eagle medium supplemented by 10% heat activated fetal calf serum, antibiotics and glutamine at 37 °C under humidified 5% CO2 atmosphere. In order to form the nodules, trypsin-dispersed cells (2.5 mL) were seeded in 6-well plates previously pre-coated with poly-2-hydroxyethylmetacrylate (PolyHEMA) (Sigma, Paris, France) according to our
PolyHEMA Coating: A Well Adapted Method for Primary Culture of Human Tumors
On noncoated surface of culture dish, HT29 human colon cancer cells were growing as a monolayer, whereas on polyHEMA-coated surface, tumor cells organized in three dimension nodules (Fig. 1). As human tumors are composed of a wide spectrum of genotypes and phenotypes, we then tested various human cancer cell lines with different genetic characteristics. Tumor cell growth was evaluated by colorimetric assay WST-1, and all the tumor cell lines tested (i.e., A427, Mia-PaCa2, DU145, PC3) were able
Discussion
In the treatment of metastatic colorectal cancer, each therapeutic line which fails delays and decreases the chances of success. An ex vivo model allowing to test on a small tissue sample several chemotherapeutic agents could help to avoid the prescription of ineffective drugs. In the present study, we evaluated the feasibility and the relevance of culture of tumor fragments in order to predict chemosensitivity or chemoresistance. Using polyHEMA coated surface, we have established a simple and
References (26)
- et al.
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicenter randomized trial
Lancet
(2000) - et al.
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: A prospective community-based feasibility study (RASTER)
Lancet Oncol
(2007) - et al.
In vitro growth ability and chemosensitivity of gastric and colorectal cancer cells assessed with the human tumor clonogenic assay and the thymidine incorporation assay
Eur J Cancer
(1992) - et al.
Global cancer statistics, 2002
CA Cancer J Clin
(2005) - et al.
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control
J Natl Cancer Inst
(2008) - et al.
Resection of hepatic metastases from colorectal cancer. Biologic perspective
Ann Surg
(1989) - et al.
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
J Clin Oncol
(2000) - et al.
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: The Gruppo Oncologico Nord Ovest
J Clin Oncol
(2007) - et al.
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
N Engl J Med
(2004) - et al.
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
N Engl J Med
(2004)
Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: Practical pharmacogenomics arrives in cancer therapy
J Clin Oncol
Human cell lines as models for multidrug resistance in solid tumors
Cytotechnology
Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces
Int J Cancer
Cited by (10)
Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: C-Src and hexokinase II
2013, Biochimica et Biophysica Acta - General SubjectsCitation Excerpt :In addition to its apoptosis-inducing properties, our study further demonstrates the newfound effects of oroxylin A on anoikis-sensitization and glycolysis-inhibition, indicating that this flavanoid from a Chinese herb could prove to be a potential candidate for the treatment of metastatic cancers. In this study, the 3D architecture of cell culture was adopted to study anoikis because it resembles the in vivo environment more closely than conventional 2D culture [36]. By comparing the cellular biological differences between the 2D and 3D cultures, we found that ROS-mediated activation of c-Src was necessary for the anoikis resistance of A549 cells (Fig. 2).
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review
2023, Langenbeck's Archives of SurgeryChemotherapy outcome predictive effectiveness by the Oncogramme: Pilot trial on stage-IV colorectal cancer
2016, Journal of Translational MedicineDefining and managing expectations for early immunotherapy cancer trials
2015, Reviews on Recent Clinical Trials